In this episode, I discuss motor neuron disease with neurologist Kevin Talbot.
We explore his dual clinical and research perspectives of the disease as portrayed in his co-authored book.
Kevin Talbot is Professor of Motor Neuron Biology, and Head of the Nuffield Department of Clinical Neurosciences, University of Oxford He is a clinician scientist with 25 years of experience of diagnosing and managing MND and related diseases.
Kevin Talbot leads the Neurodegeneration and Cerebrovascular Theme of the Oxford Biomedical Research Centre, and the main focus of his laboratory research is to improve pre-clinical models of amyotrophic lateral sclerosis, focussing on early stage disease.
His laboratory has identified disease-specific phenotypes in motor neurons which provide the tools for screening drugs of potential therapeutic benefit in ALS.
His research is closely linked to work being carried out by his Oxford colleagues on biomarkers with application to experimental medicine studies to accelerate translation of promising drugs.
Watch it on YouTube:https://youtu.be/ned7xumoRKo
Listen to it on Spotify:https://open.spotify.com/episode/4WkD00i7aBjOjcOf3CvgDY Listen to it on RSS feed
https://rss.com/podcasts/theneurologylounge/1628754/
Listen to it on Apple podcastshttps://tinyurl.com/4fetwr2z ***
And don’t forget to subscribe for the weekly episodes!
The Neurology Lounge 